Depression Is a Major Determinant of Functional Capacity in Rheumatoid Arthritis.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
01 Sep 2021
01 Sep 2021
Historique:
pubmed:
1
8
2020
medline:
18
9
2021
entrez:
1
8
2020
Statut:
ppublish
Résumé
The aim of this study was to determine the prevalence of depression among rheumatoid arthritis (RA) Argentinean patients and its association with sociodemographic and clinical factors. We performed a cross-sectional study of consecutive adults with RA. Sociodemographic data, comorbidities, RA disease activity, and current treatment were assessed. The following instruments were used to evaluate quality of life (EQ-5D-3 L [EURO Quality 5-dimension 3 lines], QOL-RA [Quality of Life-Rheumatoid Arthritis]), functional capacity (HAQ-A [Health Assessment Questionnaire-Argentinean version]), and depression (PHQ-9 [Patient Health Questionnaire 9]; scores 5-9: mild, 10-14: moderate, 15-19: moderate-severe, and ≥20: severe depression, a cutoff value ≥10 is diagnostic of major depression). Two hundred fifty-eight patients were included, with a median disease duration of 9 years (interquartile range, 3.6-16.7 years). The m PHQ-9 score was 6 (interquartile range, 2-12.3 years). The prevalence of major depression was 33.8%. The frequency of mild, moderate, moderate/severe, and severe depression was 66 (25.6%), 42 (16.3%), 27 (10.5%), and 18 (7%), respectively. Patients with major depression had worse functional capacity (HAQ-A: mean ± SD, 1.6 ± 0.8 vs. 0.7 ± 0.7; p < 0.0001), poorer quality of life (QOL-RA: mean ± SD, 5.4 ± 1.8 vs. 7.3 ± 1.6; p < 0.0001), greater pain (visual analog scale: mean ± SD, 56.2 ± 27.5 mm vs. 33.4 ± 25.7 mm; p < 0.0001), higher disease activity (Disease Activity Score in 28 joints: mean ± SD, 4.3 ± 1.4 vs. 3.3 ± 1.3; p < 0.0001), higher frequency of comorbidities (67% vs. 33%; p = 0.017), and lower frequency of physical activity (22% vs. 35%; p = 0.032). In the multivariate analysis, patients with moderate and severe depression had worse functional capacity (odds ratio, 2.1; 95% confidence interval, 1.6-4.3; p < 0.0001) and quality of life (odds ratio, 0.7; 95% confidence interval, 0.5-0.8; p < 0.0001), independently of disease activity. A third of RA patients in this Argentinean cohort had major depression. In those patients, depression was associated with worst functional capacity and quality of life.
Identifiants
pubmed: 32732521
pii: 00124743-202109002-00007
doi: 10.1097/RHU.0000000000001506
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S180-S185Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
van 't Land H, Verdurmen J, Ten Have M, et al. The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J Psychosom Res . 2010;68:187–193.
Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol . 2016;12:532–542.
Nerurkar L, Siebert S, McInnes IB, et al. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry . 2019;6:164–173.
Alesci S, Martinez PE, Kelkar S, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab . 2005;90:2522–2530.
Hestad KA, Tønseth S, Støen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT . 2003;19:183–188.
Beurel E, Lowell JA. T H 17 cells in depression. Brain Behav Immun . 2018;69:28–34.
Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience . 2013;246:199–229.
Marrie RA, Hitchon CA, Walld R, et al. Increased burden of psychiatric disorders in rheumatoid arthritis. Arthritis Care Res (Hoboken) . 2018;70:970–978.
Matcham F, Rayner L, Steer S, et al. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) . 2013;52:2136–2148.
Guelfucci F, Kaneko Y, Mahlich J, et al. Cost of depression in Japanese patients with rheumatoid arthritis: evidence from administrative data. Rheumatol Ther . 2018;5:171–183.
Ang DC, Choi H, Kroenke K, et al. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol . 2005;32:1013–1019.
Boer AC, Huizinga TWJ, van der Helm-van Mil AHM. Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis. Ann Rheum Dis . 2019;78:e1.
Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis . 2017;76:1906–1910.
Strand V, Miller P, Williams SA, et al. Discontinuation of biologic therapy in rheumatoid arthritis: analysis from the Corrona RA registry. Rheumatol Ther . 2017;4:489–502.
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol . 1967;6:278–296.
Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry . 1961;4:561–571.
Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas . 1977;3:385–401.
Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med . 2001;16:606–613.
Siu AL, US Preventive Services Task Force (USPSTF). Screening for depression in adults: US preventive services task force recommendation statement. JAMA . 2016;315:380–387.
Wittkampf KA, Naeije L, Schene AH, et al. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry . 2007;29:388–395.
Gilbody S, Richards D, Brealey S, et al. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med . 2007;22:1596–1602.
Spindler A, Bellomio V, Berman A, et al. Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol . 2002;29:1166–1170.
Scublinsky D, Venarotti H, Citera G, et al. The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province. J Clin Rheumatol . 2010;16:317–321.
Di WT, Vergara F, Bertiller E, et al. Incidence and prevalence of rheumatoid arthritis in a health management organization in Argentina: a 15-year study. J Rheumatol . 2016;43:1306–1311.
Marcos J, Waimann C, Dal Pra F, et al. General characteristics of an early arthritis cohort in Argentina. Rheumatology (Oxford) . 2011;50:110–116.
Citera G, Ficco HM, Alamino RS, et al. Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina. Clin Rheumatol . 2015;34:929–933.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet . 2018;392:1789–1858.
Stagnaro JC, Cía A, Vázquez N, et al. Epidemiological study of mental health in the general population of Argentina. Vertex . 2018;XXIX:275–299.
Funovits J, Aletaha D, Bykerk V, et al. The 2010 American College of Rheumatology/European League Against Rheumatism Classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis . 2010;69:1589–1595.
EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy . 1990;16:199–208.
Isnardi CA, Capelusnik D, Schneeberger EE, et al. Validación del índice QOL-RA (Quality of Life–Rheumatoid Arthritis) en una cohorte Argentina de pacientes con Artritis Reumatoidea. Rev Argent Reumatol . 2018;29:19–25.
Citera G, Arriola M, Maldonado-Cocco J, et al. Validation and crosscultural adaptation of an argentine Spanish version of the Health Assessment Questionnaire Disability Index. J Clin Rheumatol . 2004;10:110–115.
Prevoo M, Van’ t Hof M, Kuper H, et al. Modified Disease Activity Scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum . 1995;38:44–48.
Aletaha D, Nell V, Stamm T, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther . 2005;7:R796–R806.
Smolen J, Breedveld F, Schiff M, et al. A simplified Disease Activity Index for rheumatoid arthritis for use in clinical practice. Rheumatology . 2003;42:244–257.
Ambriz Murillo Y, Menor Almagro R, Campos-González ID, et al. Health related quality of life in rheumatoid arthritis, osteoarthritis, diabetes mellitus, end stage renal disease and geriatric subjects. Experience from a general hospital in Mexico. Reumatol Clin . 2015;11:68–72.
Mella LFB, Bértolo MB, Dalgalarrondo P. Depressive symptoms in rheumatoid arthritis. Braz J Psychiatry . 2010;32:257–263.
Maldonado G, Ríos C, Paredes C, et al. Depresión en artritis reumatoide. Rev Colom Reumatol . 2017;24:84–91.
Jacob L, Rockel T, Kostev K. Depression risk in patients with rheumatoid arthritis in the United Kingdom. Rheumatol Ther . 2017;4:195–200.
Escalante A, del Rincón I, Mulrow CD. Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res . 2000;13:156–167.
Margaretten M, Julian L, Katz P, et al. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol . 2011;6:617–623.
Margaretten M, Barton J, Julian L, et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res . 2011;63:240–246.
Katz PP, Barton J, Trupin L, et al. Poverty, depression, or lost in translation? Ethnic and language variation in patient-reported outcomes in rheumatoid arthritis. Arthritis Care Res . 2016;68:621–628.
Žagar I, Delimar V, Pap M, et al. Prevalence and correlation of depressive symptoms with functional scores, therapy and disease activity among Croatian patients with rheumatoid arthritis: a preliminary study. Psychiatr Danub . 2018;30:452–458.
Soósová MS, Macejová Ž, Zamboriová M, et al. Anxiety and depression in Slovak patients with rheumatoid arthritis. J Ment Health . 2017;26:21–27.
Baerwald C, Manger B, Hueber A. Depression as comorbidity of rheumatoid arthritis. Z Rheumatol . 2019;78:243–248.
Kronisch C, McLernon DJ, Dale J, et al. Brief report: predicting functional disability: one-year results from the Scottish early rheumatoid arthritis inception cohort. Arthritis Rheumatol . 2016;68:1596–1602.
Karpouzas GA, Draper T, Moran R, et al. Trends in functional disability and determinants of clinically meaningful change over time in Hispanic patients with rheumatoid arthritis in the US. Arthritis Care Res . 2017;69:294–298.
Ton E, Bakker MF, Verstappen SM, et al. Look beyond the Disease Activity Score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis. J Rheumatol . 2012;39:22–27.
Nikiphorou E, Radner H, Chatzidionysiou K, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther . 2016;18:251.
Cordingley L, Prajapati R, Plant D, et al. Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis. Arthritis Care Res . 2014;66:861–868.
Matcham F, Ali S, Irving K, et al. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord . 2016;17:155.